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M any targets for cardiovascular disease inter-
ventions-eg, smoking, high serum choles-
terol level, and high blood pressure-are
more clear-cut and easily defined than stress. Rather
than being a unitary construct that can be indexed by a
single number or condition, stress results from personal
and environmental factors and the interactions between
those factors. Despite this complexity, recent research
has shown that it is possible to define and measure
specific sources of personal and environmental stress
that appear to increase risk of cardiovascular disease. In
this section we review (1) state-of-the-art research on
the impact of these sources of stress on risk of cardio-
vascular disease, the mechanisms of impact, and the
effects on risk of interventions to reduce stress; (2) gaps
in research on stress and risk of cardiovascular disease;
and (3) recommendations for public policies, educa-
tional programs, and research relevant to stress and
cardiovascular disease risk.
State-of-the-Art Research
Two sources of chronic environmental stress appear
to increase risk of cardiovascular disease: job strain and
social isolation. Persons working in high-strain jobs,
defined as high demands with low control over how the
demands are met, had increased incidence of coronary
heart disease in 12 of 14 studies and increased ambula-
tory blood pressure in eight cohort studies.1 The asso-
ciation between social isolation (ie, low social support)
and increased cardiovascular disease risk in healthy
populations,2 as well as poorer prognosis in patients
with coronary heart disease has been well documented.3
Another source of chronic stress linked to increased
cardiovascular disease risk is low social class.3,4
Although harder to document, a growing body of
evidence suggests that acute psychosocial stress may act
as a trigger for acute coronary heart disease events in
patients with atherosclerotic plaques that are vulnera-
ble to rupture.5'6 A biological mechanism for such
effects is suggested by laboratory studies showing in-
creased myocardial ischemia during mental challenge7
and reduced ejection fraction during anger recall8 in
patients with coronary heart disease.
Personal sources of stress -psychological distress and
depressive symptoms (not necessarily clinical depressive
disorder) -have been associated with increased coro-
nary heart disease risk in both healthy people9 and
patients with coronary heart disease.10 A considerable
body of epidemiological evidence indicates that a hostile
personality profile -cynical attitudes toward others, fre-
quent anger, and overt aggressive behavior-is another
personal factor associated with increased incidence of
cardiovascular disease.11'12
The stress factors identified above may contribute to
increased cardiovascular disease risk by increasing sym-
pathetic nervous system activity and reactivity. Both
hostility11'12 and social factors'3 might be involved in
atherogenesis or the precipitation of acute coronary
heart disease events through this biological pathway.
More extensive evidence documents an indirect effect of
stress on cardiovascular disease risk: increased levels of
established risk factors (eg, cigarette smoking) in per-
sons subjected to high stress from both personall4'15 and
environmentall6 sources.
Only a limited number of studies have evaluated the
efficacy of interventions to reduce the effects of stress
on cardiovascular disease, but the preliminary available
evidence that interventions to reduce personall7 and
environmentall8 stress may reduce cardiovascular dis-
ease risk is encouraging. Pharmacological approaches
also show promise in ameliorating the effects of stress
on cardiovascular disease risk in animal models.19
Gaps in Research
The knowledge base for the role of stress factors in
cardiovascular disease risk is far less extensive than that
for established risk factors. The strongest and most
consistent evidence documents the effect of social iso-
lation, particularly in coronary heart disease patients.
More data in larger samples will be required to establish
the role of the stress factors identified above in cardio-
vascular disease risk.
Understanding of the mechanisms through which
stress contributes to cardiovascular disease risk is simi-
larly limited. Although there is no dispute that stress
factors contribute to risk indirectly by increasing estab-
lished risk factor levels, it remains to be seen whether
any of the stress factors acts as an "independent" risk
factor for cardiovascular disease, presumably by means
of biological concomitants of acute and chronic stress.
Preliminary studies using psychosocial interventions
in secondary prevention trials are promising, but the
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studies are limited by sample size and methodological
flaws.
Few data are available on the role of stress factors in




1. More resources should be allocated to support
research on the role of stress factors in cardiovascular
disease.
2. With the forthcoming changes in the health care
system to improve the health of the population, provi-
sion should be made for the inclusion of preventive
measures aimed at reducing the effect of stress factors
on cardiovascular disease risk.
Educational Programs
1. The American Heart Association should help ed-
ucate the public and the health care community about
current understanding of the relation between personal
and environmental stressors and cardiovascular disease
risk.
2. The American Heart Association should assist in
the development, implementation, and evaluation of
stress reduction interventions in various settings, in-
cluding the worksite* and community-based cardiac
rehabilitation programs.
Research Needs
1. Research is needed to develop, and evaluate the
benefits of, interventions to reduce the effect of stress
factors on cardiovascular disease risk. Although second-
ary prevention efforts will be most informative early on,
public health approaches to primary prevention by
means of educational programs should begin soon. The
outcomes of these intervention studies will not only help
document the efficacy of the interventions but could
add to the evidence that the targeted stress factors are
contributing to cardiovascular disease risk.
2. Accelerated and expanded efforts are needed to
increase understanding of the psychological, social, be-
havioral, and biological mechanisms whereby stress
factors contribute to the etiology, course, and prognosis
of cardiovascular disease. This research should include
efforts to understand how stress factors interact, both
with each other and with established risk factors, to
increase risk.
3. Given the growing evidence for the role of stress
factors in increasing cardiovascular disease risk, even if
only an indirect contribution is clear at present, mea-
sures of the identified stress factors should be included
in ongoing and planned population studies and clinical
trials (eg, the tamoxifen trial in 15 000 women). This will
not only enlarge the data base on the role of stress
factors in cardiovascular disease risk but will also ensure
*This is already under way under the auspices of the AHA's
Program Committee.
that we take advantage of important opportunities to
prevent cardiovascular disease.
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